The following is provided by Navellier with technical comment from South Ocean Management – pls do your own due diligence.
(For this 2020 year, SOM will track only the Top 5 Hi-Growth Investments.)

https://navelliergrowth.investorplace.com/

Navellier says,

High-Growth Investments

Brown & Brown, Inc.

Brown & Brown, Inc. (BRO) is the sixth-largest insurance brokerage in the U.S., with more than 290 locations. Insurance isn’t a very sexy business, but Brown & Brown’s business model is very attractive—and it’s added to its top and bottom lines over the years. Simply put, Brown & Brown focuses first and foremost on its customers and protecting their most-valued assets.

Brown & Brown is scheduled to announce first-quarter results after the closing bell on Monday, April 27. The consensus estimate calls for earnings of $0.46 per share on revenue of $682 million, which represents 13.4% annual revenue growth and 12.2% annual earnings growth.

Analysts’ earnings estimates have remained steady over the past few months. The company has posted a positive earnings surprise in each of the last four quarters, so I wouldn’t be surprised if Brown & Brown exceeds analysts’ expectations again. BRO is a Conservative buy below $37.

SOM Technicals:

3-27-20:  Closed at 35.93. Trade pressures are rising into the neutral zone. Volumes are bullish. Need a close above 36.10 to start a new move up.

4-4-20: Closed at 33.41. Trade pressures are down. Volumes are bearish. The next target down is the 30.70 prior low.

4-11-20: Closed at 39.03. Trade pressures are up. Volumes are bullish. In the move up, the next target up is 44.85.

4-17-20: closed at 38.10. Trade pressures are down into the neutral zone. Volumes are bullish. Consolidating at the 200 day MA.

4-25-20: Closed at 34.76. Trade pressures are down. Volumes are bearish. The next target down is a retest of the lows. at 30.70.

5-2-20: Closed at 35.06. Trade pressures are down. Volumes are neutral. At the 25×5 support level. of 36.

5-8-20: Closed at 37.60. Trade pressures are up. Volumes are bullish. Still in the  move down. Need a close above 38.00 change the trend.

5-15-20: Closed at 37.00. Trade pressures are down but rising. Volumes are bullish. The new uptrend has started.

 

DexCom, Inc.

DexCom, Inc. (DXCM) has been a solid performer for us, up more than 156% since we added it to the High-Growth Investments Buy List in December 2018. The reality is that DexCom has cornered a very lucrative market: continuous glucose monitoring (CGM). The company’s CGM technology enables a diabetic to test their blood glucose levels without pricking their finger.

Strong demand for its products and services have driven DexCom’s sales and earnings growth over the years. In fiscal year 2019, the company achieved 397.3% annual earnings growth and 43.7% annual revenue growth.

DexCom will post earnings and revenue results for its first quarter in fiscal year 2020 on Tuesday, April 28 after the stock market closes. First-quarter earnings are expected to surge 380% year-over-year to $0.14 per share, up from a $0.05 per share loss in the same quarter a year ago. Analysts have upped earnings forecasts over the past three months, which means a fifth-straight quarterly earnings surprise is likely. Revenue is forecast to increase 28% year-over-year to $358.94 million. DXCM is an Aggressive buy below $381.

SOM Technicals:

4-25-20: Closed at 332.44. Trade pressures are up but declining. Volumes are bullish. New highs next target up is 350.00.

5-2-20: Closed at 341.52. Trade pressures are down into,the neutral zone. Volumes remain bullish. The pull back could go to 304 and still be in the uptrend.

5-8-20: Closed at 405.50. Trade pressures are up. Volumes are bullish; some selling into this big rally.

5-15-20: Closed at 417.13. Trade pressures are up but declining. Volumes are neutral. support is at 381.00.

 

Microsoft Corporation

Microsoft Corporation (MSFT) is a big-name technology company that’s most well-known for its Windows operating systems. There are currently more than 900 million devices utilizing the latest Windows operating system, Windows 10. And, amidst the coronavirus pandemic, the company’s Microsoft Teams platform has enabled businesses to work remotely together, with group chats, video meetings, calls and collaborative workspaces.

Company management noted that it’s seen a dramatic increase in demand for Microsoft Teams and Microsoft 365, as businesses around the world enabled their employees to work remotely. Microsoft Teams has also helped many schools and universities better connect students and educators.

Still, Microsoft stated that interruptions to supply chains due to the coronavirus likely impacted the company’s top and bottom lines in its third quarter in fiscal year 2020. Analysts, however, have actually increased earnings forecasts over the past three months. The current consensus estimate calls for earnings of $1.24 per share, or 13.2% annual earnings growth.

We’ll have a clearer picture on Microsoft’s fundamentals on Wednesday, April 29, as the company is scheduled to announce third-quarter results. For now, the company is benefiting from an influx in buying pressure and strong top- and bottom-line growth. MSFT is a Conservative buy below $182.

SOM Technicals:

4-25-20: Closed at 174.55. Trade pressures are down into the neutral zone. Volumes are neutral. The next target up is 196.00. Consolidating at the 62% upside target .

5-2-20: Closed at 174.57. Trade pressures are up but near the neutral zone. Volumes are neutral. Consolidating around the 178 100 % target.

5-8-20: Closed at 184.68. Trade pressures are up. Volumes are bullish. the next target up is 192.31.

5-15-20: Closed at 183.16. Trade pressures are up. Volumes are bullish. The next target up is 192.31

 

ResMed, Inc.

ResMed, Inc. (RMD) is a leading provider of respiratory solutions, as the company offers CPAP devices and other life support ventilators in more than 120 countries around the world. In response to the coronavirus pandemic, ResMed is planning to double, and possibly triple, its production of ventilators and ventilation masks. These efforts are aimed at aiding in treatment of patients diagnosed with the coronavirus—and should also add to the company’s top and bottom lines.

ResMed is set to report earnings and sales for its third quarter in fiscal year 2020 after the stock market closes on Thursday, April 30. The company is expected to report earnings of $1.05 per share, or 18% annual earnings growth, and revenue of $720.4 million. Analysts have also upped earnings forecasts over the past three months, which bodes well for a fifth-straight quarterly earnings surprise.

I should also add that ResMed continues to reward its shareholders with quarterly dividends. Most recently, the company paid a dividend of $0.39 per share on March 19. RMD has climbed nicely higher with other dividend stocks recently, jumping 48% in the past five weeks. RMD is a Conservative buy below $169.

SOM Technicals:

3-27-20: Closed at 141.95. Trade pressures are up. Volumes are bullish. In the new move up from the 129.46 long entry price.

4-4-20: Closed at 152.97. Trade pressures are up into the neutral zone. Volumes are bullish. The next target up is 1182.81.

4-11-20: Closed at 152.97. Trade pressures are up into the neutral zone. Volumes are bullish. The next target up is 182.81.

4-17-20: Closed at 165.16. Trade pressures are up. Volumes are bullish. The next target up is the 177.99 prior high.

4-25-20: Closed at 161.90. Trade pressures are down but rising. Volumes are now neutral. At the upside 62% target. Expect consolidation.

5-2-20: Closed at 159.07. Trade pressures are up. Volumes are bearish. At the 62% target and in consolidation.

5-8-20: Closed at 162.75. Trade pressures are up. Volumes are bullish. In consolidation at the 162 target level.

5-15-20: Closed at 164.12. Trade pressures are down but rising. Volumes are bullish. Consolidating at the 162 target level. The next target up is 180.00.

 

Vipshop Holdings Ltd.

Vipshop Holdings Ltd. (VIPS) was added to the High-Growth Investments Buy List in the April Growth Investor Monthly Issue, as the company is set to benefit from an influx in online orders in China. You may recall that Vipshop Holdings is an online discount retailer of brand-name consumer goods. And the company has a very loyal following, with 69 million active users.

Vipshop Holdings is expected to announce results for its first quarter in fiscal year 2020 in mid-May—and analysts are expecting another blowout quarter. Earnings estimates have been revised a stunning 242.3% in the past two months alone.

Overall, the analyst community is looking for earnings of $0.89 per ADS and revenue of $18.3 billion. That represents 512.6% annual revenue growth and 423.5% annual earnings growth. VIPS is an Aggressive buy below $18.

SOM Technicals:

4-25-20: Closed at 16.09. Trade pressures are down. Volumes are bearish. Support at the 25×5 MA at 16.00.

5-2-20: Closed at 15.20. Trade pressures are down. Volumes are bearish. In a new move down. The next target down is 11.53.

5-8-20. Closed at 17.18. Trade pressures are down but rising. Volumes are bullish. Ripped higher at the close. Need a close above 17.25 to change the trend.

5-15-20: Closed at 16.85. Trade pressures are down, but rising. Volumes are bullish. The next target up is 18.95.